-
1
-
-
0035883897
-
Rheumatoid arthritis
-
Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 358(9285), 903-911 (2001).
-
(2001)
Lancet
, vol.358
, Issue.9285
, pp. 903-911
-
-
Lee, D.M.1
Weinblatt, M.E.2
-
3
-
-
84905647565
-
Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A synopsis
-
Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am. J. Manag. Care. 20(7. Suppl.), S128-S135 (2014).
-
(2014)
Am. J. Manag. Care.
, vol.20
, Issue.7
, pp. S128-S135
-
-
Gibofsky, A.1
-
4
-
-
1542671584
-
Multicentric study of the prevalence of adult rheumatoid arthritis in Brazilian population samples
-
Marques-Neto J, Gonçalves E, Langen L, Cunha M, Radominski S, Oliveira S. Multicentric study of the prevalence of adult rheumatoid arthritis in Brazilian population samples. Rev. Bras. Reumatol. 33, 169-173 (1993).
-
(1993)
Rev. Bras. Reumatol.
, vol.33
, pp. 169-173
-
-
Marques-Neto, J.1
Gonçalves, E.2
Langen, L.3
Cunha, M.4
Radominski, S.5
Oliveira, S.6
-
5
-
-
1542724885
-
Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach
-
Senna ER, De Barros AL, Silva EO et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J. Rheumatol. 31, 594-597 (2004).
-
(2004)
J. Rheumatol.
, vol.31
, pp. 594-597
-
-
Senna, E.R.1
De Barros, A.L.2
Silva, E.O.3
-
6
-
-
84859309049
-
2012 Brazilian society of rheumatology consensus for the treatment of rheumatoid arthritis
-
da Mota LM, Cruz BA, Brenol CV et al. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev. Bras. Reumatol. 52, 152-174 (2012).
-
(2012)
Rev. Bras. Reumatol.
, vol.52
, pp. 152-174
-
-
Da Mota, L.M.1
Cruz, B.A.2
Brenol, C.V.3
-
7
-
-
77953696525
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
-
Smolen JS, Landewé R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. 69, 964-975 (2010).
-
(2010)
Ann. Rheum.
, vol.69
, pp. 964-975
-
-
Smolen, J.S.1
Landewé, R.2
Breedveld, F.C.3
-
8
-
-
84859832981
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
-
Singh JA, Furst DE, Bharat A et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 64, 625-639 (2012).
-
(2012)
Arthritis Care Res.
, vol.64
, pp. 625-639
-
-
Singh, J.A.1
Furst, D.E.2
Bharat, A.3
-
9
-
-
80054980301
-
-
Constituição da República Fedeativa do Brasil. Brasil
-
BRASIL. Senado Federal. Constituição da República Fedeativa do Brasil. Brasil (1988). www.planalto.gov.br/ccivil-03
-
(1988)
Senado Federal
-
-
BRASIL1
-
11
-
-
33847588216
-
-
Secretaria de Atenção à Saúde. Portaria n. 865, de 25 de novembro de 2002. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil
-
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria n. 865, de 25 de novembro de 2002. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2002). www.saudedireta.com.br/docsupload
-
(2002)
Ministério da Saúde
-
-
BRASIL1
-
12
-
-
33847588216
-
-
Secretaria de Atenção à Saúde. Portaria n. 66, de 1 de novembro de 2006. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil
-
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria n. 66, de 1 de novembro de 2006. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2006). http://bvsms.saude.gov.br/bvs/saudelegis
-
(2006)
Ministério da Saúde
-
-
BRASIL1
-
13
-
-
84962495978
-
Implementation of clinical guidelines in Brazil: Should academic detailing be used?
-
Costa JO, Almeida-Brasil CC, Godman B et al. Implementation of clinical guidelines in Brazil: should academic detailing be used? J. Pharm. Health Services Res. 7(2), 105-115 (2016).
-
(2016)
J. Pharm. Health Services Res.
, vol.7
, Issue.2
, pp. 105-115
-
-
Costa, J.O.1
Almeida-Brasil, C.C.2
Godman, B.3
-
14
-
-
33847588216
-
-
Departamento de Informática do SUS - DATASUS. Informações em saúde (TABNET). Assistência a Saúde. Produção ambulatorial. DATASUS
-
BRASIL. Ministério da Saúde. Departamento de Informática do SUS - DATASUS. Informações em saúde (TABNET). Assistência a Saúde. Produção ambulatorial. DATASUS, 2016. www2.datasus.gov.br/DATASUS
-
(2016)
Ministério da Saúde
-
-
BRASIL1
-
15
-
-
33644804877
-
The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): A review of their usefulness and validity in rheumatoid arthritis
-
Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin. Exp. Rheumatol. 23(Suppl. 39), S100-S108 (2005).
-
(2005)
Clin. Exp. Rheumatol.
, vol.23
, pp. S100-S108
-
-
Aletaha, D.1
Smolen, J.2
-
16
-
-
0037229712
-
The stanford health assessment questionnaire: A review of its history, issues, progress, and documentation
-
Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J. Rheumatol. 30, 100-108 (2003).
-
(2003)
J. Rheumatol.
, vol.30
, pp. 100-108
-
-
Bruce, B.1
Fries, J.F.2
-
17
-
-
0025688231
-
EuroQol - A new facility for the measurement of health-related quality of life
-
EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Pol. 16, 199-208 (1990).
-
(1990)
Health Pol.
, vol.16
, pp. 199-208
-
-
-
18
-
-
84952909836
-
Brazilian valuation of EQ-5D-3L health states: Results from a saturation study
-
Santos M, Cintra MA, Monteiro AL et al. Brazilian valuation of EQ-5D-3L health states: results from a saturation study. Med. Decis. Making 36(2), 253-263 (2015).
-
(2015)
Med. Decis. Making
, vol.36
, Issue.2
, pp. 253-263
-
-
Santos, M.1
Cintra, M.A.2
Monteiro, A.L.3
-
20
-
-
33846079219
-
The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis
-
Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J. Rheumatol. 33, 2398-2408 (2006).
-
(2006)
J. Rheumatol.
, vol.33
, pp. 2398-2408
-
-
Gartlehner, G.1
Hansen, R.A.2
Jonas, B.L.3
Thieda, P.4
Lohr, K.N.5
-
21
-
-
0142156483
-
Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis
-
Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 62(Suppl. 2), ii13-ii16 (2003).
-
(2003)
Ann. Rheum. Dis.
, vol.62
, pp. ii13-ii16
-
-
Hochberg, M.C.1
Tracy, J.K.2
Hawkins-Holt, M.3
Flores, R.H.4
-
22
-
-
38749141455
-
Systematic review: Comparative effectiveness and harms of diseasemodifying medications for rheumatoid arthritis
-
Donahue KE, Gartlehner G, Jonas DE et al. Systematic review: comparative effectiveness and harms of diseasemodifying medications for rheumatoid arthritis. Ann. Intern. Med. 148, 124-134 (2008).
-
(2008)
Ann. Intern. Med.
, vol.148
, pp. 124-134
-
-
Donahue, K.E.1
Gartlehner, G.2
Jonas, D.E.3
-
23
-
-
84992030477
-
What is the best biological for arthritis rheumatoid? A systematic review of effectiveness
-
Dos Santos JB, Costa JO, Oliveira Junior HA et al. What is the best biological for arthritis rheumatoid? A systematic review of effectiveness. World J. Rheumatol. 5(2), 108-126 (2015).
-
(2015)
World J. Rheumatol.
, vol.5
, Issue.2
, pp. 108-126
-
-
Dos Santos, J.B.1
Costa, J.O.2
Oliveira Junior, H.A.3
-
24
-
-
84944811040
-
Comparing effects of biologic agents in treating patients with rheumatoid arthritis: A multiple treatment comparison regression analysis
-
Tvete IF, Natvig B, Gåsemyr J, Meland N, Røine M, Klemp M. Comparing effects of biologic agents in treating patients with rheumatoid arthritis: a multiple treatment comparison regression analysis. PLoS ONE 10(9), e0137258 (2015).
-
(2015)
PLoS ONE
, vol.10
, Issue.9
, pp. e0137258
-
-
Tvete, I.F.1
Natvig, B.2
Gåsemyr, J.3
Meland, N.4
Røine, M.5
Klemp, M.6
-
25
-
-
80052977037
-
A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis
-
Turkstra E, Ng SK, Scuffham PA. A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis. Curr. Med. Res. Opin. 27(10), 1885-1897 (2011).
-
(2011)
Curr. Med. Res. Opin.
, vol.27
, Issue.10
, pp. 1885-1897
-
-
Turkstra, E.1
Ng, S.K.2
Scuffham, P.A.3
-
26
-
-
81355123266
-
A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis
-
Mandema JW, Salinger DH, Baumgartner SW, Gibbs MA. A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis. Clin. Pharmacol. Ther. 90(6), 828-835 (2011).
-
(2011)
Clin. Pharmacol. Ther.
, vol.90
, Issue.6
, pp. 828-835
-
-
Mandema, J.W.1
Salinger, D.H.2
Baumgartner, S.W.3
Gibbs, M.A.4
-
27
-
-
78650747686
-
Effectiveness of biologic therapies for rheumatoid arthritis: An indirect comparisons approach
-
Devine EB, Alfonso-Cristancho R, Sullivan SD. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy 31(1), 39-51 (2011).
-
(2011)
Pharmacotherapy
, vol.31
, Issue.1
, pp. 39-51
-
-
Devine, E.B.1
Alfonso-Cristancho, R.2
Sullivan, S.D.3
-
28
-
-
84924978245
-
Randomized, doubleblind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
-
Hobbs K, Deodhar A, Wang B et al. Randomized, doubleblind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy. Springerplus 4, 113 (2015).
-
(2015)
Springerplus
, vol.4
, pp. 113
-
-
Hobbs, K.1
Deodhar, A.2
Wang, B.3
-
29
-
-
84892449972
-
Remission in rheumatoid arthritis patients treated with etanercept monotherapy: Clinical practice and clinical trial experience
-
Cannon GW, Wang BC, Park GS, Koenig A, Collier DH, Keystone EC. Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience. Clin. Exp. Rheumatol. 31(6), 919-925 (2013).
-
(2013)
Clin. Exp. Rheumatol.
, vol.31
, Issue.6
, pp. 919-925
-
-
Cannon, G.W.1
Wang, B.C.2
Park, G.S.3
Koenig, A.4
Collier, D.H.5
Keystone, E.C.6
-
30
-
-
84906725127
-
Older age at rheumatoid arthritis onset and comorbidities correlate with less health assessment questionnaire-disability index and clinical disease activity index response to etanercept in the RADIUS 2 registry
-
Martin WJ, Shim M, Paulus HE et al. Older age at rheumatoid arthritis onset and comorbidities correlate with less health assessment questionnaire-disability index and clinical disease activity index response to etanercept in the RADIUS 2 registry. J. Clin. Rheumatol. 20(6), 301-305 (2014).
-
(2014)
J. Clin. Rheumatol.
, vol.20
, Issue.6
, pp. 301-305
-
-
Martin, W.J.1
Shim, M.2
Paulus, H.E.3
-
31
-
-
84867809188
-
Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
-
Canhão H, Rodrigues AM, Mourão AF et al. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford) 51, 2020-2026 (2012).
-
(2012)
Rheumatology (Oxford)
, vol.51
, pp. 2020-2026
-
-
Canhão, H.1
Rodrigues, A.M.2
Mourão, A.F.3
-
32
-
-
84862563304
-
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: Results from the US CORRONA registry
-
Greenberg JD, Reed G, Decktor D et al. A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry. Ann. Rheum. Dis. 71, 1134-1142 (2012).
-
(2012)
Ann. Rheum. Dis.
, vol.71
, pp. 1134-1142
-
-
Greenberg, J.D.1
Reed, G.2
Decktor, D.3
-
33
-
-
84906791823
-
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
-
Hirabara S, Takahashi N, Fukaya N et al. Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies. Clin. Rheumatol. 33(9), 1247-1254 (2014).
-
(2014)
Clin. Rheumatol.
, vol.33
, Issue.9
, pp. 1247-1254
-
-
Hirabara, S.1
Takahashi, N.2
Fukaya, N.3
-
34
-
-
38649098475
-
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelveweek study
-
Burmester GR, Ferraccioli G, Flipo RM et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelveweek study. Arthritis Rheum. 59(1), 32-41 (2008).
-
(2008)
Arthritis Rheum.
, vol.59
, Issue.1
, pp. 32-41
-
-
Burmester, G.R.1
Ferraccioli, G.2
Flipo, R.M.3
-
35
-
-
79953906254
-
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up
-
Bartelds GM, Krieckaert CL, Nurmohamed MT et al. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. JAMA 305(14), 1460-1468 (2011).
-
(2011)
JAMA
, vol.305
, Issue.14
, pp. 1460-1468
-
-
Bartelds, G.M.1
Krieckaert, C.L.2
Nurmohamed, M.T.3
-
36
-
-
84882261762
-
Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: Systematic review and meta-analysis
-
Maneiro JR, Salgado E, Gomez-Reino JJ. Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis. JAMA Intern Med. 173(15), 1416-1428 (2013).
-
(2013)
JAMA Intern Med.
, vol.173
, Issue.15
, pp. 1416-1428
-
-
Maneiro, J.R.1
Salgado, E.2
Gomez-Reino, J.J.3
-
37
-
-
33751416149
-
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
-
Hyrich KL, Watson KD, Silman AJ, Symmons DP. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45(12), 1558-1565 (2006).
-
(2006)
Rheumatology (Oxford)
, vol.45
, Issue.12
, pp. 1558-1565
-
-
Hyrich, K.L.1
Watson, K.D.2
Silman, A.J.3
Symmons, D.P.4
-
38
-
-
43049162899
-
Treatment response to a second or third TNF-inhibitor in RA: Results from the South Swedish Arthritis Treatment Group Register
-
Karlsson JA, Kristensen LE, Kapetanovic MC, Gülfe A, Saxne T, Geborek P. Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 47(4), 507-513 (2008).
-
(2008)
Rheumatology (Oxford)
, vol.47
, Issue.4
, pp. 507-513
-
-
Karlsson, J.A.1
Kristensen, L.E.2
Kapetanovic, M.C.3
Gülfe, A.4
Saxne, T.5
Geborek, P.6
-
39
-
-
43049169008
-
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: Results from the South Swedish Arthritis Treatment Group Register
-
Kristensen LE, Kapetanovic MC, Gülfe A, Söderlin M, Saxne T, Geborek P. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 47(4), 495-499 (2008).
-
(2008)
Rheumatology
, vol.47
, Issue.4
, pp. 495-499
-
-
Kristensen, L.E.1
Kapetanovic, M.C.2
Gülfe, A.3
Söderlin, M.4
Saxne, T.5
Geborek, P.6
-
40
-
-
11144355274
-
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
-
van de Putte LBA, Atkins C, Malaise M et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann. Rheum. Dis. 63(5), 508-516 (2004)
-
(2004)
Ann. Rheum. Dis.
, vol.63
, Issue.5
, pp. 508-516
-
-
Van De-Putte, L.B.A.1
Atkins, C.2
Malaise, M.3
-
41
-
-
33947594031
-
The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis
-
Dore RK, Mathews S, Schechtman J et al. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 25(1), 40-46 (2007).
-
(2007)
Clin. Exp. Rheumatol.
, vol.25
, Issue.1
, pp. 40-46
-
-
Dore, R.K.1
Mathews, S.2
Schechtman, J.3
-
43
-
-
0036169930
-
Guidelines for the management of rheumatoid arthritis: 2002 Update
-
American College Rheumatology Subcommittee On Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 46(2), 328-346 (2002).
-
(2002)
Arthritis Rheum.
, vol.46
, Issue.2
, pp. 328-346
-
-
-
44
-
-
84893772728
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
-
Smolen JS, Landewé R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492-509 (2013).
-
(2013)
Ann. Rheum. Dis.
, vol.73
, Issue.3
, pp. 492-509
-
-
Smolen, J.S.1
Landewé, R.2
Breedveld, F.C.3
-
45
-
-
84856315340
-
-
Secretaria de Atenção à Saúde. Portaria SAS/MS n° 996, de 30 de setembro de. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2015)
-
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria SAS/MS n° 996, de 30 de setembro de 2015. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2015). http://bvsms.saude.gov.br/bvs/saudelegis/sas
-
(2015)
Ministério da Saúde
-
-
BRASIL1
-
46
-
-
84898627870
-
Review: Treat to target in rheumatoid arthritis: Fact, fiction, or hypothesis?
-
Solomon DH, Bitton A, Katz JN et al. Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol. 66(4), 775-782 (2014).
-
(2014)
Arthritis Rheumatol.
, vol.66
, Issue.4
, pp. 775-782
-
-
Solomon, D.H.1
Bitton, A.2
Katz, J.N.3
-
47
-
-
77950307115
-
Treating rheumatoid arthritis to target: Recommendations of an international task force
-
Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631-637 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 631-637
-
-
Smolen, J.S.1
Aletaha, D.2
Bijlsma, J.W.3
-
48
-
-
84870265734
-
Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission
-
Jurgens MS, Welsing PM, Jacobs JW. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin. Exp. Rheumatol. 30(4, Suppl. 73), S56-S63 (2012).
-
(2012)
Clin. Exp. Rheumatol.
, vol.30
, Issue.4
, pp. S56-S63
-
-
Jurgens, M.S.1
Welsing, P.M.2
Jacobs, J.W.3
-
49
-
-
77950309959
-
Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search
-
Schoels M, Knevel R, Aletaha D et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann. Rheum. Dis. 69(4), 638-643 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, Issue.4
, pp. 638-643
-
-
Schoels, M.1
Knevel, R.2
Aletaha, D.3
-
50
-
-
84889983501
-
Treating to the target of remission in early rheumatoid arthritis is cost-effective: Results of the DREAM registry
-
Vermeer M, Kievit W, Kuper HH et al. Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet. Disord. 14, 350 (2013).
-
(2013)
BMC Musculoskelet. Disord.
, vol.14
, pp. 350
-
-
Vermeer, M.1
Kievit, W.2
Kuper, H.H.3
-
51
-
-
84903479861
-
Roles of nurse practitioners and physician assistants in rheumatology practices in the US
-
Solomon DH, Bitton A, Fraenkel L, Brown E, Tsao P, Katz JN. Roles of nurse practitioners and physician assistants in rheumatology practices in the US. Arthritis Care Res. 66(7), 1108-1113 (2014).
-
(2014)
Arthritis Care Res.
, vol.66
, Issue.7
, pp. 1108-1113
-
-
Solomon, D.H.1
Bitton, A.2
Fraenkel, L.3
Brown, E.4
Tsao, P.5
Katz, J.N.6
-
52
-
-
84055191578
-
Treat-to-target from the patient perspective
-
Gromnica-Ihle E, Rink M. Treat-to-target from the patient perspective. Z. Rheumatol. 70(8), 678-684 (2011).
-
(2011)
Z. Rheumatol.
, vol.70
, Issue.8
, pp. 678-684
-
-
Gromnica-Ihle, E.1
Rink, M.2
-
53
-
-
65849105320
-
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis
-
Greenberg JD, Harrold LR, Bentley MJ, Kremer J, Reed G, Strand V. Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis. Rheumatology (Oxford) 48(6), 686-690 (2009).
-
(2009)
Rheumatology (Oxford)
, vol.48
, Issue.6
, pp. 686-690
-
-
Greenberg, J.D.1
Harrold, L.R.2
Bentley, M.J.3
Kremer, J.4
Reed, G.5
Strand, V.6
-
54
-
-
84992127542
-
The performance of the clinical disease activity index in patients with rheumatoid arthritis
-
Gunaydin R, Karatepe AG, Kaya T. The performance of the clinical disease activity index in patients with rheumatoid arthritis. Turk. Romatoloji. Dergisi. 21, 45-48 (2006).
-
(2006)
Turk. Romatoloji. Dergisi.
, vol.21
, pp. 45-48
-
-
Gunaydin, R.1
Karatepe, A.G.2
Kaya, T.3
-
55
-
-
80052428536
-
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
-
Klarenbeek NB, Koevoets R, van der Heijde DM et al. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Ann. Rheum. Dis. 70(10), 1815-1821 (2011).
-
(2011)
Ann. Rheum. Dis.
, vol.70
, Issue.10
, pp. 1815-1821
-
-
Klarenbeek, N.B.1
Koevoets, R.2
Van Der-Heijde, D.M.3
-
56
-
-
84880395911
-
Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: An Indian experience
-
Singh H, Kumar H, Handa R, Talapatra P, Ray S, Gupta V. Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: an Indian experience. Arthritis 2011, 146398 (2011)
-
(2011)
Arthritis
, vol.2011
, pp. 146398
-
-
Singh, H.1
Kumar, H.2
Handa, R.3
Talapatra, P.4
Ray, S.5
Gupta, V.6
|